Clinical Trial Update: A Clinical Study to Evaluate the Pharmacokinetics and Safety of Anecatibin Fumarate Capsules in Subjects With Impaired Liver Function Versus Normal Liver Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of Anecatibin Fumarate Capsules in subjects with impaired liver function versus normal liver function; the trial is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Anecatibin Fumarate Capsules (Anecatibin Fumarate)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Lung Cancer | Phase 1 | Status: NOT_YET_RECRUITING